Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogene complementation in fetal brain transplants.

O D Wiestler1, A Aguzzi, M Schneemann

  • 1Department of Pathology, University of Zürich, Switzerland.

Cancer Research
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.

Cell death & disease·2026
Same author

GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.

Virchows Archiv : an international journal of pathology·2025
Same author

Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries.

Molecular biology reports·2024
Same author

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort.

Journal of neuro-oncology·2023
Same author

Analysis of co-isogenic prion protein deficient mice reveals behavioral deficits, learning impairment, and enhanced hippocampal excitability.

BMC biology·2022
Same author

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.

The British journal of dermatology·2020
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Introducing oncogenes v-Ha-ras and v-myc into developing rat brains initiated tumor formation. Co-expression of both ras and myc oncogenes rapidly generated highly malignant neural neoplasms in vivo and in vitro.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Neural progenitor cells are susceptible to oncogenic transformation.
  • Understanding the mechanisms of neural tumor development is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the oncogenic potential of v-Ha-ras and v-myc in the developing rat brain.
  • To explore the synergistic effects of ras and myc co-expression on neural progenitor cells.

Main Methods:

  • Retrovirus-mediated gene transfer of v-Ha-ras and v-myc oncogenes into developing rat brains and neural cultures.
  • Histochemical analysis (S-100 protein, beta-galactosidase) to detect gene expression and tumor formation.
  • In vivo neural transplantation and in vitro cell culture models.

Related Experiment Videos

Main Results:

  • Single oncogene (v-Ha-ras or v-myc) introduction led to tumor formation in a subset of cases after a latency period.
  • Co-expression of v-Ha-ras and v-myc resulted in rapid, highly malignant, polyclonal neoplasms in all recipients.
  • Neoplastic transformation was observed both in vivo and in vitro, demonstrating the complementary transforming effect of ras and myc.

Conclusions:

  • The ras and myc oncogenes exhibit a powerful complementary transforming effect on neural progenitors.
  • Co-expression of ras and myc provides an efficient method for transforming neural precursor cells for research purposes.
  • This model system offers insights into neural oncogenesis and potential therapeutic targets.